Search results
With whooping cough cases on the rise, do you need a booster vaccine?
Fox News via Yahoo News· 23 hours agoAs whooping cough (pertussis) cases surge globally, experts offer their insights on symptoms,...
New Hampshire's GOP are taking a stand—against the polio vaccine
Mother Jones· 3 days agoFight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that...
Measles is a preventable disease: What parents need to know about measles, vaccines
The Columbian· 11 hours agoMeasles is a highly contagious disease caused by the measles virus. Fortunately, measles is a ...
RFK Jr’s presidential bid saps more support from Trump than Biden, poll finds
The Independent US via AOL· 1 day agoAnti-vaccine activist and conspiracy theorist Robert F Kennedy Jr’s long-shot presidential bid...
FDA Approves ImmunityBio's Bladder Cancer Drug, Stock Rallies
Benzinga via Yahoo Finance· 5 hours ago(N-803, or nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guérin (BCG) for...
New ‘100-day cough’ warning as cases soar 40% in a week - is your area at risk?
The US Sun· 4 days agoA total of 824 Brits are believed to have fallen ill with the bacterial infection in the week...
This year's measles case total is now the highest in the U.S. since 2019
NBC News via Yahoo News· 6 hours agoThe U.S. measles case total is now the highest of the last five years, according to the CDC. Around...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 4 days agoBut Moderna turned in per-share losses of $12.33, reversing from a year-earlier gain of $20.12 a...
Fauci hosted 2013 meeting where Baric laid out plans to make coronaviruses more lethal
World Tribune· 4 days agoOn June 24, 2013, the National Institutes of Health (NIH) hosted a meeting featuring Ralph Baric who...
GSK Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 4 hours agoWe expect GSK's specialty products like Arexvy, Cabenuva, Juluca, Dovato, Nucala, Trelegy Ellipta and Shingrix to drive first-quarter sales performance.